| Brand Name | Solace Biotech |
|---|---|
| Industry / Business Category | Healthcare Products / Pharmaceutical Services |
| Founded Year | 2000 |
| Franchise Started | 2000 |
| Total Franchise Outlets | 200–500 |
| Estimated Investment | INR 10,000–50,000 |
| Franchise/Brand Fee | INR 25,000 |
| Royalty Fee | 10% of revenue |
| Space Requirement | Not specified; typically small office or storage space for distribution |
| Staff Requirement | Sales representatives, administrative personnel |
| Expected Payback Period | Varies depending on sales volume; often under 1 year for active districts |
Solace Biotech operates in the pharmaceutical industry, providing a broad portfolio of healthcare products through its PCD (Propaganda Cum Distribution) Pharma Franchise model. The brand supplies tablets, capsules, syrups, injectables, and specialty formulations across multiple therapeutic segments including gastroenterology, dermatology, cardiology, and pain management. Its services cater to small-scale distributors, chemists, and healthcare providers. This franchise falls under the broader pharmaceutical distribution and healthcare franchise category.
Franchise partners manage sales and distribution of Solace Biotech products within an exclusive geographic area, often district-wise. Customers, including chemists, clinics, and hospitals, place orders through the franchisee. Franchise operations include inventory management, order processing, and distribution logistics. Revenue is generated primarily from product sales and ongoing distribution of high-demand pharmaceutical items.
Franchise outlets handle:
The product range allows franchisees to serve diverse customer needs within their territory.
Franchise partners operate as independent distributors under Solace Biotech’s PCD model. Responsibilities include managing local sales, maintaining inventory, and ensuring timely delivery. The franchisor provides exclusive territory rights, marketing support, training, and supply chain facilitation. Franchisees follow standardized operational processes to ensure consistent product quality and customer service.
| Estimated Investment | INR 10,000–50,000 for initial stock and basic setup |
|---|---|
| Franchise Fee | INR 25,000 |
| Royalty | 10% of revenue |
| Setup Costs | Office/storage space, initial inventory, basic marketing materials |
| Operational Costs | Staff salaries, transportation, utilities |
Investment is low relative to traditional retail franchises due to small-scale distribution operations.
| Space | Suitable for office and storage of pharmaceutical inventory; typically small-scale setup |
|---|---|
| Location | Commercial areas accessible to chemists and medical stores |
| Equipment | Storage racks, computers, basic office furniture |
| Staffing | Minimum of one sales executive or representative and administrative support |
Efficient inventory handling and order processing are key operational considerations.
Solace Biotech provides:
This support aims to reduce operational risk and improve franchisee profitability.
Revenue is derived from the sale of pharmaceutical products to chemists, hospitals, and clinics. Demand drivers include healthcare needs, seasonal sales patterns, and expansion of medical services in semi-urban and rural areas. Repeat business comes from replenishment orders and expanding customer bases within assigned territories. Expected payback periods can be under 12 months depending on local demand.
Founded in 2000, Solace Biotech has over 20 years of experience in pharmaceutical production and distribution. The franchise model began in the same year, establishing a nationwide network of 200–500 outlets. The brand operates across India, including urban and semi-urban districts, with plans to expand further into underserved regions where demand for quality pharmaceutical products is rising.
The operational distinction of Solace Biotech lies in its district-wise PCD model providing monopoly distribution rights, which limits direct competition within territories. Franchisees gain access to a broad product portfolio, training, and marketing support while managing a low-capital, distribution-focused business. This contrasts with typical pharmaceutical franchises that may require larger retail setups and broader operational commitments.
Suitable for:
These brands offer similar franchise opportunities with focus on PCD or regional pharmaceutical distribution networks.
The model does not require dedicated retail or clinic space; it can be operated from a small office or storage point sufficient to hold inventory and manage paperwork, since the business runs on distribution rather than walk-in footfall.
There is no fit-out in the retail sense. What franchisees typically need to arrange themselves is basic storage suited to pharmaceutical stock, billing and inventory tracking tools, and transport arrangements for dispatch to stockists and chemists.
Training generally centers on product and formulation knowledge, documentation required under the drug license, and guidance on managing stockist relationships and order cycles, rather than customer-service training in the retail sense.
The operation mode is semi-absentee, so day-to-day order processing and dispatch can be handled by trained staff, but franchisees who stay personally engaged in collections and key account relationships tend to see steadier outcomes than those who step back entirely.
Acquisition in this business happens through field outreach to doctors and retailers rather than consumer advertising, and franchisees are generally expected to build and maintain that referral network themselves, often with promotional schemes or literature provided by the parent company to support the conversation.
Disclaimer: All scores, rankings, and estimates on ForeFind are independently produced editorial assessments using publicly available data and validated brand-submitted information. They are not verified facts, financial advice, or investment recommendations. Full Disclaimer.